Fundz

Flamingo Therapeutics Appoints Ezra Cohen as Chief Medical Officer

PRIVATEMar 21, 2024

Position

Chief Medical Officer

Company

Flamingo Therapeutics

Ezra Cohen, MD
LeuvenBiotechnologyHealth CareTherapeutics

Description

Flamingo Therapeutics appoints Ezra Cohen, MD, as a new board member with unique expertise in oncology drug development and cancer research, enhancing the company's position in advancing therapeutic options for patients with head and neck cancer.

Quick answer

Flamingo Therapeutics Appoints Ezra Cohen as Chief Medical Officer (March 21, 2024). Flamingo Therapeutics is based in Leuven, Flemish Brabant, Belgium.

What did Flamingo Therapeutics announce on March 21, 2024?
Flamingo Therapeutics appoints Ezra Cohen, MD, as a new board member with unique expertise in oncology drug development and cancer research, enhancing the company's position in advancing therapeutic options for patients with head and neck cancer.
What does Flamingo Therapeutics do?
Flamingo is pioneering RNA-targeted therapies for oncology with state-of-the art chemistries and a clinical-stage pipeline targeting undruggable transcription factors and splice variants.
Where is Flamingo Therapeutics based?
Flamingo Therapeutics is based in Leuven, Flemish Brabant, Belgium.
Which similar companies made leadership changes around the same time?
MaaT Pharma (March 21, 2024), BeiGene Ltd (March 20, 2024), Arvinas (March 20, 2024) and BioNTech (March 20, 2024) also announced leadership changes within 45 days of Flamingo Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Flamingo Therapeutics, and when

A new leader at Flamingo Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Flamingo Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Flamingo Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Flamingo Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Flamingo Therapeutics

Location

Leuven, Flemish Brabant, Belgium

About

Flamingo is pioneering RNA-targeted therapies for oncology with state-of-the art chemistries and a clinical-stage pipeline targeting undruggable transcription factors and splice variants. Flamingo Therapeutics has a Phase II trial (PEMDA-HN) evaluating the STAT3 targeting agent danvatirsen, in combination with pembrolizumab, in patients with head and neck squamous cell carcinoma (HNSCC). Flamingo has an alliance with Ionis Pharmaceuticals and is supported by well-known biotechnology investors including Andera Partners, Bpifrance Large Venture, Bpifrance through its FABS and Fonds Biothérapies Innovantes et Maladies Rares funds, Eurazeo - Kurma Partners, Perceptive Advisors, PMV, Pontifax, Sphera, funds managed by Tekla Capital Management LLC and VIB.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Flamingo Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Flamingo Therapeutics's next move

Learn about Strategic plan

Flamingo Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.